Samsung Biologics Co.,Ltd. (KRX:207940)
South Korea · Delayed Price · Currency is KRW 1,548,000
-16,000 (-1.02%)
At close: Aug 14, 2026
Samsung Biologics Stock Forecast
Stock Price Forecast
According to 25 analysts polled by S&P Global, Samsung Biologics stock has a consensus rating of "Strong Buy" and an average price target of ₩1,975,520. The average 1-year stock price forecast is 27.62% higher than the current stock price, while the lowest is ₩1,600,000 (+3.36%) and the highest is ₩2,200,000 (+42.12%).
Price Target: ₩1,975,520 (+27.62%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Samsung Biologics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 16 | 16 | 15 | 14 | 13 | 15 |
| Buy | 10 | 9 | 9 | 10 | 10 | 10 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 26 | 25 | 24 | 24 | 23 | 25 |
Financial Forecast
Revenue This Year
5.46T
from 4.56T
Increased by 19.77%
Revenue Next Year
6.38T
from 5.46T
Increased by 16.85%
EPS This Year
41.19K
from 26.63K
Increased by 54.67%
EPS Next Year
49.22K
from 41.19K
Increased by 19.51%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.